Transcriptional Reprogramming and Novel Therapeutic Approaches for Targeting Prostate Cancer Stem Cells
Prostate cancer is the most common malignancy in men and the second cause of cancer-related deaths in western countries. Despite the progress in the treatment of localized prostate cancer, there is still lack of effective therapies for the advanced forms of the disease. Most patients with advanced p...
Main Authors: | Gianluca Civenni, Domenico Albino, Dheeraj Shinde, Ramiro Vázquez, Jessica Merulla, Aleksandra Kokanovic, Sarah N. Mapelli, Giuseppina M. Carbone, Carlo V. Catapano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-05-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fonc.2019.00385/full |
Similar Items
-
Expression and ERG regulation of PIM kinases in prostate cancer
by: Sini K. Eerola, et al.
Published: (2021-05-01) -
Past, Current, and Future Strategies to Target ERG Fusion-Positive Prostate Cancer
by: Francesca Lorenzin, et al.
Published: (2022-02-01) -
ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
by: Ian Y. Luk, et al.
Published: (2018-08-01) -
Mitochondrial fission promotes self-renewal and tumorigenic potential in prostate cancer
by: Gianluca Civenni, et al.
Published: (2019-09-01) -
Prostate cancer with different ERG status may show different FOXP3-positive cell numbers
by: Karolina Kaczmarczyk-Sekuła, et al.
Published: (2017-02-01)